000008034 001__ 8034
000008034 005__ 20240510125305.0
000008034 0247_ $$2DOI$$a10.6083/p2676w00t
000008034 037__ $$aETD
000008034 245__ $$aInitiative to improve door to needle times in acute ischemic stroke treatment
000008034 260__ $$bOregon Health and Science University
000008034 269__ $$a2020
000008034 336__ $$aFinal project
000008034 502__ $$bD.N.P.
000008034 520__ $$aAcute ischemic stroke affects 696,000 people annually and is a leading cause of disability in the United States. Tissue plasminogen activator (tPA) is the mainstay of treatment with earlier administration associated with improved benefits.  Despite this, less than one third of patients in the United States are treated with tPA in less than 60 minutes from presentation.  With significant improvements in multiple stroke outcomes appreciated with each 15-minute improvement in door to needle (DTN) time, reduction of DTN is essential to improve outcomes and reduce disability. Stroke related disability imposes a significant economic burden, further supporting the need to decrease treatment times and improve stroke outcomes.  Telestroke technology was placed within the Computed Tomography (CT) imaging suites at two institutions to improve DTN times when a stroke neurologist is not on-site.  A retrospective review of the Providence Stroke Registry was conducted to determine median DTN time for patients treated with tPA in the emergency department.
000008034 542__ $$fIn copyright - single owner
000008034 650__ $$aTelemedicine$$029784
000008034 650__ $$aQuality Improvement$$039456
000008034 650__ $$aIschemic Stroke$$013354
000008034 691__ $$aSchool of Nursing$$041370
000008034 7001_ $$aJamieson, Sarah$$uOregon Health and Science University$$041354
000008034 8564_ $$976a4555c-e0b6-41a8-96b5-b80437a215d1$$s296452$$uhttps://digitalcollections.ohsu.edu/record/8034/files/Jamieson.Sarah.2020.pdf
000008034 905__ $$a/rest/prod/p2/67/6w/00/p2676w00t
000008034 909CO $$ooai:digitalcollections.ohsu.edu:8034$$pstudent-work
000008034 980__ $$aTheses and Dissertations